|
Market Closed -
Bombay S.E.
06:02:28 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 1,992.20 INR | -0.79% |
|
+1.15% | +39.90% |
| 08-14 | Ipca Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026 | |
| 08-13 | Ipca Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 1,325.39 | +13.78% | 29 | |||||||
| 277.91 | +3.13% | 22 | |||||||
| 278.61 | +5.34% | 28 | |||||||
| 375.34 | +2.89% | 19 | |||||||
| 152.66 | +7.94% | 22 | |||||||
| 211.28 | +25.8% | 23 | |||||||
| 387.69 | -1.39% | 29 | |||||||
| 308.86 | +18.79% | 23 | |||||||
| 158.15 | +5.04% | 27 | |||||||
| 28.88 | +4.09% | 26 | |||||||
| 570.07 | +11.62% | 28 | |||||||
| 66.71 | +6.53% | 24 | |||||||
| 94.06 | +26.1% | 24 | |||||||
| 21.71 | +13.61% | 21 | |||||||
| 9,323.33 | +38.21% | 15 | |||||||
| 6,622.06 | +10.96% | 16 | |||||||
| 58.22 | +18.75% | 18 | |||||||
| 71.35 | +54.98% | 17 | |||||||
| Average | 1,129.57 | +14.79% | 23 | ||||||
| Weighted average by Cap. | 726.58 | +10.44% | 25 |
Select your edition
All financial news and data tailored to specific country editions
















